Target Name: ZBED5
NCBI ID: G58486
Other Name(s): OTTHUMP00000197107 | ZBED5_HUMAN | zinc finger BED-type containing 5 | FLJ41239 | ZBED5 variant 1 | OTTHUMP00000231034 | transposon-derived Buster1 transposase-like protein | OTTHUMP00000231038 | Buster1 | Transposon-derived Buster1 transposase-like protein | Zinc finger BED-type containing 5, transcript variant 1 | Zinc finger BED domain-containing protein 5 | OTTHUMP00000231035

ZBED5: A Protein with Potential as A Drug Target and Biomarker

ZBED5 (Zinc Finger Enzyme-Like 5) is a protein that is expressed in various tissues and cells throughout the body. It is characterized by its unique structure, which consists of a long amino acid sequence followed by a zinc finger domain. ZBED5 has been shown to play a role in a variety of cellular processes, including cell signaling, DNA replication, and metabolism.

One of the most interesting aspects of ZBED5 is its potential as a drug target. The zinc finger domain of ZBED5 is known for its ability to interact with various molecules, including small molecules, peptides, and even drugs. This interaction makes ZBED5 a potentially attractive target for drug development.

ZBED5 has been shown to play a role in a variety of diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, ZBED5 has been shown to be overexpressed in various types of cancer, including breast, lung, and colorectal cancer. This suggests that targeting ZBED5 with drugs that can inhibit its activity may be a promising strategy for cancer treatment.

In addition to its potential as a drug target, ZBED5 also has interesting biological properties that make it a potential biomarker. The zinc finger domain of ZBED5 is known for its ability to interact with small molecules, including drugs that are used to treat various diseases. This interaction suggests that ZBED5 may be able to serve as a biomarker for a variety of conditions, including cancer, neurodegenerative diseases, and autoimmune disorders.

In conclusion, ZBED5 is a protein that has significant potential as a drug target and biomarker. Its unique zinc finger domain and ability to interact with small molecules make it a promising target for drug development. Further research is needed to fully understand the role of ZBED5 in various biological processes and to develop effective treatments for the diseases associated with its dysfunction.

Protein Name: Zinc Finger BED-type Containing 5

More Common Targets

ZBED5-AS1 | ZBED6 | ZBP1 | ZBTB1 | ZBTB10 | ZBTB11 | ZBTB11-AS1 | ZBTB12 | ZBTB12BP | ZBTB14 | ZBTB16 | ZBTB17 | ZBTB18 | ZBTB2 | ZBTB20 | ZBTB21 | ZBTB22 | ZBTB24 | ZBTB25 | ZBTB26 | ZBTB3 | ZBTB32 | ZBTB33 | ZBTB34 | ZBTB37 | ZBTB38 | ZBTB39 | ZBTB4 | ZBTB40 | ZBTB41 | ZBTB42 | ZBTB43 | ZBTB44 | ZBTB44-DT | ZBTB45 | ZBTB45P2 | ZBTB46 | ZBTB46-AS1 | ZBTB47 | ZBTB48 | ZBTB49 | ZBTB5 | ZBTB6 | ZBTB7A | ZBTB7B | ZBTB7C | ZBTB7C-AS2 | ZBTB8A | ZBTB8B | ZBTB8OS | ZBTB8OSP1 | ZBTB9 | ZC2HC1A | ZC2HC1B | ZC2HC1C | ZC3H10 | ZC3H11A | ZC3H11B | ZC3H11C | ZC3H12A | ZC3H12A-DT | ZC3H12B | ZC3H12C | ZC3H12D | ZC3H13 | ZC3H14 | ZC3H15 | ZC3H18 | ZC3H18-AS1 | ZC3H3 | ZC3H4 | ZC3H6 | ZC3H7A | ZC3H7B | ZC3H8 | ZC3HAV1 | ZC3HAV1L | ZC3HC1 | ZC4H2 | ZCCHC10 | ZCCHC12 | ZCCHC13 | ZCCHC14 | ZCCHC14-DT | ZCCHC17 | ZCCHC18 | ZCCHC2 | ZCCHC24 | ZCCHC3 | ZCCHC4 | ZCCHC7 | ZCCHC8 | ZCCHC9 | ZCRB1 | ZCWPW1 | ZCWPW2 | ZDBF2 | ZDHHC1 | ZDHHC11 | ZDHHC11B